-
The data access committee for "Validation of cfDNA fragmentome analyses for early detection of liver cancer"
Dac
EGAC00001003543
-
Whole Exome Sequences of Human Embryonic Stem Cell Lines
Study
phs001343
-
BC Cancer, part of the Provincial Health Services Authority, Technology Development Office, Data Access Committee (PHSA TDO DAC)
Dac
EGAC00001003254
-
Institute for Refractory Cancer Research (IRCR) Data Access Committee
Dac
EGAC00001000272
-
Wargo Group Data Access Committee for Neodjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
Dac
EGAC00001001008
-
Evaluating the immune response in treatment-naive hospitalised patients with influenza and COVID-19 Data Access Committee
Dac
EGAC00001002503
-
Orolova hIPSC data access policy
Dac
EGAC50000000744
-
Neuroblastoma cell-lines and healthy cfDNA used for the benchmarking study
Dataset
EGAD50000002199
-
University of Utah Pelvic Organ Prolapse Disorder Study
Study
phs001439
-
CINECA synthetic data.Please note: This study contains synthetic data (with cohort “participants” / ”subjects” marked with FAKE) has no identifiable data and cannot be used to make any inference about cohort data or results.
Study
EGAS00001002472